Polarographic behaviour and determination of acrivastine in capsules and human urine

被引:14
作者
Abdine, H [1 ]
Belal, F [1 ]
机构
[1] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh 11451, Saudi Arabia
关键词
acrivastine; polarography; capsules; urine;
D O I
10.1016/S0039-9140(01)00539-2
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A sensitive method for the quantitative determination of acrivastine was developed based on the reduction of the drug at the dropping mercury electrode. A well-developed polarographic wave was produced in Britton-Robinson buffers over the pH range 0.0-11. The overall reduction process was diffusion-controlled with limited adsorption properties. At pH 5, the diffusion-current constant (I-d) was 5.45 +/- 0.05 (n = 9). The current versus concentration plot was linear over the range 1.2 - 20.0 and 0.4 - 12.0 mug/ml using the direct current tast (DCt) and differential pulse polarography modes, respectively, with a minimum delectability (S/N = 3) of 0.03 mug/ml (8.6 x 10(-7) M) using the latter technique. The mechanism for the reduction was suggested and the number of electrons involved in the electrode reduction was established. The method was applied for the determination of acrivastine in capsules. Pseudoephedrine, which is frequently co-formulated with acrivastine, did not interfere with the assay. The method was also successfully applied to spiked human urine, the percent recovery (n = 3) was 97.07 with a confidence limit (t.s.) of +/- 2.33. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:97 / 104
页数:8
相关论文
共 16 条
[1]   Spectrophotometric determination of acrivastine in urine and capsules [J].
Abdine, HH ;
Gazy, AA ;
Blaih, SM ;
Korany, MA .
TALANTA, 1996, 43 (10) :1643-1648
[2]   Quantitative determination of acrivastine and pseudoephedrine hydrochloride in pharmaceutical formulation by high performance liquid chromatography and derivative spectrophotometry [J].
Altuntas, TG ;
Zanooz, SS ;
Nebioglu, D .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 17 (01) :103-109
[3]  
BONEVA AS, 1983, KHIM FARM ZH+, V17, P1133
[4]   QUANTITATIVE GAS-CHROMATOGRAPHIC MASS-SPECTROMETRIC ANALYSIS OF ACRIVASTINE AND A METABOLITE IN HUMAN-PLASMA [J].
CHANG, SY ;
NELSON, FR ;
FINDLAY, JWA ;
TAYLOR, LCE .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1989, 497 :288-295
[5]   Application of derivative and ratio spectra derivative spectrophotometry for the determination of pseudoephedrine hydrochloride and acrivastine in capsules [J].
Dinc, E ;
Onur, F .
ANALYTICAL LETTERS, 1997, 30 (06) :1179-1191
[6]  
Estelle F, 1999, CLIN PHARMACOKINET, V36, P329
[7]  
GIBSON JR, 1989, J INT MED RES, V17, pB28
[8]  
HEYROVSKY J, 1965, PRINCIPLES POLAROGRA, P82
[9]   Colorimetric and fluorimetric methods for the determination of some antihistaminics using acid dyes and charge transfer techniques [J].
Karam, H ;
El Kousy, N ;
Towakkol, M .
ANALYTICAL LETTERS, 1999, 32 (01) :79-96
[10]  
LIBERMAN HA, 1989, PHARM DOSAGE FORMS T, V1, P184